MARC record from Internet Archive

LEADER: 06994cam 22008894a 4500
001 ocm49221945
003 OCoLC
005 20200725085904.0
008 020225s2002 ja a b 101 0 eng
010 $a 2002019376
040 $aDNLM/DLC$beng$cDLC$dNLM$dOHX$dBAKER$dNLGGC$dBTCTA$dYDXCP$dOCLCG$dHEBIS$dIG#$dBDX$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dCASUM$dOCLCO$dOCLCA$dOCLCF$dUKMGB$dOCLCO$dOCLCA$dNHN$dOCLCA$dL2U$dOCLCO$dOCLCA$dQ2U
066 $c$1
016 7 $a964491478$2DE-101
016 7 $a101138986$2DNLM
016 7 $a006601987$2Uk
020 $a4431703322$q(alk. paper)
020 $a9784431703327$q(alk. paper)
035 $a(OCoLC)49221945
042 $apcc
050 00 $aRD546$b.K454 2001
060 00 $aWI 770$bK27c 2002
072 7 $aRD$2lcco
082 00 $a617.5/5620592$221
084 $a44.87$2bcl
084 $aM18$aSC547$2kktb
111 2 $aKeio International Symposium for Life Sciences and Medicine$n(9th :$d2001)
245 10 $aCurrent issues in liver and small bowel transplantation /$cM. Kitajima [and others], (eds.).
260 $aTokyo ;$aNew York :$bSpringer,$c©2002.
300 $axvi, 186 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aKeio University international symposia for life sciences and medicine ;$v9
504 $aIncludes bibliographical references and index.
505 00 $gPt. 1.$tTechnical Aspects and Physiological Problems in Split/Living Donor Liver Transplantation --$tLiving-Donor Liver Transplantation: Experience at Shinshu University /$rS. Kawasaki --$tLiver Splitting for Two Adult Patients and Domino Liver Transplantation: The Paul Brousse Experience /$rR. Adam, D. Azoulay and D. Castaing /$r[et al.] --$tLiving-Donor Liver Transplantation in Taiwan /$rY.-S. Chen, C.-L. Chen and V. H. de Villa /$r[et al.] --$tImpact of Small-for-Size Graft on Graft Surgical and Postoperative Complications in Adult Living Donor Liver Transplantation /$rK. Tanaka --$tLiving-Donor Liver Transplantation Using Left-Liver Graft and Hepatic Vein Reconstruction /$rM. Makuuchi and Y. Sugawara --$tResults of Living-Donor Liver Transplantation in Hong Kong /$rS.-T. Fan, C.-M. Lo and C.-L. Liu /$r[et al.] --$tMiddle Hepatic Vein Reconstruction in Living-Donor Liver Transplantation Using the Right Lobe /$rS. G. Lee --$gPt. 2.$tViral Hepatitis and Liver Transplantation --$tLiver Transplantation for Hepatitis B and C /$rJ. J. Fung --$tStrategies for the Treatment of Hepatitis B and C After Liver Transplantation /$rU. P. Neumann, D. Seehofer and J. M. Langrehr /$r[et al.] --$tProphylaxis and Posttransplant Treatment of Viral Hepatitis in Living-Donor Liver Transplantation /$rT. Ichida and Y. Satoh --$gPt. 3.$tCurrent Status and Future Prospects in Small Bowel Transplantation --$tIntestinal Transplantation /$rA. N. Langnas --$tClinical Experience of Small Bowel/Multivisceral Transplantation at the University of Miami /$rS. Nishida, T. Kato and D. Levi /$r[et al.] --$tIntestinal Transplantation at the University of Pittsburgh /$rJ. J. Fung, J. Reyes and N. Murase /$r[et al.] --$tIntestinal Transplantation in Children: Experience of a Single Center in Paris /$rO. Goulet, D. Jan and F. Lacaille /$r[et al.] --$tLiving-Donor Small Bowel Transplantation: Experience of Three Cases /$rS. Uemoto, S. Kaihara and A. Yokoi /$r[et al.] --$tSmall Bowel Transplantation as a Final Treatment for Intestinal Failure /$rA. Okada, T. Hasegawa and M. Wasa /$r[et al.] --$gPt. 4.$tLiver transplantation for Malignant Hepatic Tumors --$tThe Role of Liver Transplantation in the Treatment of Primary Liver Tumors /$rP. Neuhaus and S. Jonas --$tLong-Term Results of Transplantation for Hepatocellular Carcinoma With or Without Cirrhosis: 15 Years'-Experience at Paul Brousse Hospital /$rR. Adam, D. Azoulay and D. Castaing /$r[et al.] --$tLiving Donor Liver Transplantation for Malignant Hepatic Tumors /$rK. Tanaka --$gPt. 5.$tNovel Strategies in Immunosuppression --$tOptimizing the Use of Neoral in Liver and Kidney Transplantation by C[subscript 2] Monitoring /$rG. A. Levy --$tThe Interleukin 2 "Pathway" and the Route to Logical Immunosuppression /$rB. Nashan --$tFTY720: Mechanisms of Action and Immunosuppressive Activity in Organ Transplantation /$rS. Suzuki --$tNovel Strategies for Living Donor Liver Transplantation Across the ABO Blood Group Barrier: Effect of Intraportal Infusion Therapy /$rM. Tanabe, M. Shimazu and G. Wakabayashi /$r[et al.] --$tKey Word Index.
650 0 $aLiver$xTransplantation$vCongresses.
650 0 $aIntestine, Small$xTransplantation$vCongresses.
650 0 $aTransplantation of organs, tissues, etc$vCongresses.
650 12 $aLiver Transplantation$xmethods.$0https://id.nlm.nih.gov/mesh/D016031Q000379
650 22 $aHepatitis, Viral, Human$xsurgery.$0https://id.nlm.nih.gov/mesh/D006525Q000601
650 22 $aImmunosuppression$xmethods.$0https://id.nlm.nih.gov/mesh/D007165Q000379
650 22 $aIntestine, Small$xtransplantation.$0https://id.nlm.nih.gov/mesh/D007421Q000637
650 22 $aLiver Neoplasms$xsurgery.$0https://id.nlm.nih.gov/mesh/D008113Q000601
650 22 $aLiving Donors.$0https://id.nlm.nih.gov/mesh/D019520
650 7 $a44.87 gastroenterology.$0(NL-LeOCL)077596889$2bcl
650 7 $aLiver$xTransplantation.$2fast$0(OCoLC)fst01000691
650 7 $aTransplantation of organs, tissues, etc.$2fast$0(OCoLC)fst01154919
650 7 $aLebertransplantation$2gnd
650 7 $aDünndarmtransplantation$2gnd
650 17 $aLever.$2gtt
650 17 $aDunne darm.$2gtt
650 17 $aTransplantatie.$2gtt
651 7 $aTokio <2002>$2swd
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
655 4 $aCongresses.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
700 1 $6880-01$aKitajima, Masaki,$d1941-2019.
776 08 $iOnline version:$aKeio International Symposium for Life Sciences and Medicine (9th : 2001).$tCurrent issues in liver and small bowel transplantation.$dTokyo ; New York : Springer, ©2002$w(OCoLC)606046023
830 0 $aKeio University international symposia for life sciences and medicine ;$v9.
856 $31850-9999$uhttp://www.springer.com/gb/$xBLDSS
880 1 $6700-01/$1$a北島, 政樹,$d(1941- )
938 $aBaker & Taylor$bBKTY$c189.00$d189.00$i4431703322$n0003927287$sactive
938 $aBrodart$bBROD$n59010991$c$149.00
938 $aBaker and Taylor$bBTCP$n2002019376
938 $aOtto Harrassowitz$bHARR$nhar025012538
938 $aIngram$bINGR$n9784431703327
938 $aYBP Library Services$bYANK$n1863764
029 1 $aAU@$b000023411663
029 1 $aGEBAY$b6779033
029 1 $aHEBIS$b105026921
029 1 $aNLGGC$b238868184
029 1 $aNLM$b101138986
029 1 $aNZ1$b6786526
029 1 $aYDXCP$b1863764
029 1 $aUKMGB$b006601987
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 110 OTHER HOLDINGS